Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...